Johnson Matthey (JMPLY)
(Delayed Data from OTC)
$44.52 USD
+0.59 (1.34%)
Updated Jul 12, 2024 01:09 PM ET
5-Strong Sell of 5 5
A Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
JMPLY 44.52 +0.59(1.34%)
Will JMPLY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for JMPLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JMPLY
Johnson Matthey (JMPLY) Sells Medical Device Unit for $700M
Is Hawkins (HWKN) Stock Outpacing Its Basic Materials Peers This Year?
JMPLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Johnson Matthey (JMPLY) Stock Undervalued Right Now?
JMPLY vs. AIQUY: Which Stock Is the Better Value Option?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Other News for JMPLY
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
IN BRIEF: Johnson Matthey launches tranche of GBP250 million buyback
Deutsche Numis Sticks to Its Buy Rating for Johnson Matthey (JMAT)
Gelion shares soar 57% following announcement of Glencore partnership